The role of Candida in inflammatory bowel disease. Estimation of transmission of C. albicans fungi in gastrointestinal tract based on genetic affinity between strains

Medical Science Monitor

Volumn 16, Issue 10, 2010, Pages

  Trojanowska, Danuta ^a   Zwolinska Wcislo, Małgorzata ^a   Tokarczyk, Marianna ^a   Kosowski, Krzysztof ^b   Mach, Tomasz ^a   Budak, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b Hospital of the Ministry of Interior and Administration   (Poland)

Author keywords

Candida; Colonoscopy; Inflammatory bowel disease; PCR RAPD

Indexed keywords

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; COMPARATIVE STUDY; CONTROLLED STUDY; ENTERITIS; FEMALE; FUNGAL STRAIN; FUNGUS TRANSMISSION; GASTROINTESTINAL TRACT; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NONHUMAN; ACUTE DISEASE; ADOLESCENT; CANDIDA; CASE CONTROL STUDY; CROHN DISEASE; DRUG EFFECT; FUNGUS; GENETICS; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MOUTH; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; ULCERATIVE COLITIS; FUNGAL COLONIZATION; FUNGAL DETECTION; FUNGAL GENETICS; FUNGUS CULTURE; FUNGUS ISOLATION; GENETIC VARIABILITY; HUMAN TISSUE; MOUTH CAVITY; PATHOGENESIS; QUANTITATIVE ANALYSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CANDIDA; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FUNGI; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MOUTH; MYCOSES; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; YOUNG ADULT;

EID: 77958109537     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fatahzadeh M: Inflammatory bowel disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009; 108: e1-e10
2. Pinto A, Chebli L, Ribeiro M et al: Azathioprine therapy in steroid-dependent patients with Crohn disease: Results of a 10-year longitudinal follow-up study Med Sci Monit, 2009; 15(5): PI19-26
3. Chamberlin WM, Naser SA: Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses. Med Sci Monit, 2006; 12(2): RA27-33
4. Head KA, Jurenka JS: Inflammatory bowel disease Part I: ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern Med Rev, 2003; 8(3): 247-83
5. Head KA, Jurenka JS: Inflammatory bowel disease. Part II: Crohn's disease-pathophysiology and conventional and alternative treatment options. Altern Med Rev, 2004; 9(4): 360-401
6. Lindsay JO, Whelan K, Staag AJ et al: Clinical, microbiological, and immunological effects of fructo-oligosacharide in patients with Crohn's disease. Gut, 2006; 55: 348-55
7. Bamis G, Nyce MR, De La Rue SA et al: New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med, 2005; 143:895-904
8. Zwolinska-Wcislo M, Brzozowski T, Budak A et al: Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J Physiol Pharmacol, 2009; 60(1): 107-18
9. Kuehbacher T, Ott SJ, Helwig U et al: Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut, 2006; 55: 833-41
10. Dzierzanowska-Fangrat K, Dzierzanowska D: Diagnostyka inwazyjnych zakażeń grzybiczych. Zakażenia, 2007; 1: 78-82 [in Polish]
11. Adamski Z, Zawirska A: Grzybice przewodu pokarmowego. Mikol Lek, 2007; 15: 174-79 [in Polish]
12. Adamski Z, Batura-Gabryel H (eds.): Mikologia lekarska. Poznań: Wydawnictwo Naukowe Uniwersytetu Medycznego w Poznaniu, 2005; 117-26, 133-38 [in Polish]
13. Zwolińska-Wcisło M, Budak A, Bogdał J: Fungal colonization of gastric mucosa and its clinical relevance. Med Sci Monit, 2001; 7(5): 982-88
14. Santelmann H, McLaren H: Yeast metabolic products, yeast antigens and yeasts as possibile triggers for irritable bowel syndrome. Eur J Gastroenterol Hepatol, 2005; 17(1): 21-26
15. Scheurlen M: Pathogenicity of fungi in the intestines - current status of the discussion. Fortschr Med, 1996; 114(26): 319-21
16. Dzierżanowska D (ed.). Zakażenia grzybicze - wybrane zagadnienia, a-medica press 2006; 3: 40-49 [in Polish]
17. Eckburg PB, Bik EM, Bernstein CN et al: Diveristy of the human intestinal microbial flora. Science, 2005; 308: 1635-38
18. Müller J: Characteristics of fungus carries as source of infection. Zentr Hyg Umwel, 1993; 294(1-4): 162-72
19. Belckum A, Melchers W, Pauw E et al: Genotypic characterization of sequential Candida albicans isolates from fluconazole-treated neutropenic patients. J Inf Diseases, 1999; 196: 1062-70
20. Vrioni G, Matsiota-Bernard P: Molecular typing of Candida albicans isolates from patients hospitalized in an intensive care unit. J Inf, 2001; 42: 50-56
21. Herold G (ed.): Medycyna wewne{ogonek}trzna - repetytorium dla studentów medycyny i lekarzy. Warszawa: Wydawnictwo Lekarskie PZWL; 2003. p. 511-20 [in Polish]
22. Sartor RB: Review article: role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther, 1997; 11(Suppl.3): 17-23
23. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapetics. Gastroenterol, 2001; 120: 622-35
24. Batura-Gabryel H: Grzybice głe{ogonek}bokie wyste{ogonek}puja{ogonek}ce w Polsce. Mikol Lek, 2007; 13: 137-45 [in Polish]
25. Crohn's & Colitis Foundation of America. Opportunistic Infections In Inflammtory Bowel Disease. 2006; Available at: URL: http://www.ccfa.org
26. Höchter W, Seeliger HP: Fungus colonization in colitis. Dtsch Med Wochenschr, 1983; 108(11): 416-18
27. Swidsinski A, Weber J, Loening-Baucke V et al: Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol, 2005; 43: 3380-89
28. Ruhnke M: Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets, 2006; 7(4): 495-504
29. Zwolińska-Wcisło M, Budak A, Trojanowska D et al: Wpływ kolonizacji grzybów Candida na przebieg wrzodzieja{ogonek}cego zapalenia jelita grubego. Przegl Lek, 2006; 63(7): 533-38 [in Polish]
30. Gionchetti P, Rizzello F, Lammers KM et al: Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol, 2006; 12(21): 3306-13